Who owns Quoin Pharmaceuticals Ltd.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of QNRX from SEC Form 13F filings across 18 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 18 institutions disclosed 1.2M shares of Quoin Pharmaceuticals Ltd. worth $5.8M — about 59.7% of shares outstanding; the largest disclosed holder is Dauntless Investment Group, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
18
13F holders
$5.8M
value, 2026 filers
59.7%
of shares outstanding (1.2M sh)
1
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of QNRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Dauntless Investment Group, LLC | 214,987 | $1.0M | 0.8% | 10.7% | +9.4% |
| 2 | Ikarian Capital, LLC | 211,538 | $1.0M | 0.1% | 10.5% | 0.0% |
| 3 | Stonepine Capital Management, LLC | 199,486 | $965,512 | 0.5% | 9.9% | +273.2% |
| 4 | MILLENNIUM MANAGEMENT LLC | 112,323 | $543,643 | 0.0% | 5.6% | +47.3% |
| 5 | Woodline Partners LP | 76,446 | $369,999 | 0.0% | 3.8% | -3.9% |
| 6 | Aberdeen Group plc | 75,000 | $363,000 | 0.0% | 3.7% | 0.0% |
| 7 | Soleus Capital Management, L.P. | 72,730 | $352,013 | 0.0% | 3.6% | 0.0% |
| 8 | AIGH Capital Management LLC | 70,000 | $338,800 | 0.0% | 3.5% | +37.3% |
| 9 | BOOTHBAY FUND MANAGEMENT, LLC | 59,838 | $289,616 | 0.0% | 3% | 0.0% |
| 10 | Velan Capital Investment Management LP | 32,372 | $156,680 | 0.1% | 1.6% | -61.8% |
| 11 | BARCLAYS PLC | 21,469 | $103,910 | 0.0% | 1.1% | +1551.5% |
| 12 | Birchview Capital, LP | 20,000 | $96,800 | 0.0% | 1% | 0.0% |
| 13 | XTX Topco LtdNEW | 15,006 | $72,629 | 0.0% | 0.7% | new |
| 14 | MORGAN STANLEY | 8,000 | $38,720 | 0.0% | 0.4% | +100.0% |
| 15 | UBS Group AG | 6,772 | $32,777 | 0.0% | 0.3% | +169.6% |
| 16 | RHUMBLINE ADVISERS | 2,332 | $11,280 | 0.0% | 0.1% | +53.3% |
| 17 | GAMMA Investing LLC | 439 | $2,125 | 0.0% | 0% | -74.5% |
| 18 | SBI Securities Co., Ltd. | 355 | $1,718 | 0.0% | 0% | +17650.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.